11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

 

Videos
34:39

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

Genomic/Molecular Profiling & Targeting Adaptive Resistance in BC: Replication Stress & PARPi, (K)RAS Mutations, Adaptive Multi-Drug Treatment, Olaparib Mono

FEATURING Gordon Mills
  • 122 views
  • February 26, 2021
45:55

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Axilla Management Updates: Omitting SLND, cN- (SLN+ & Elderly Patients), cN+ (Clipped Nodes, Outcomes With Omission of ALND), Impact of RxPonder

FEATURING Abigail Caudle
  • 200 views
  • February 26, 2021
27:54

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Updates on Adjuvant ET in ER+ BC: How Do Genomic Studies Guide ET Decision Choice? Is Abemaciclib+ET Effective in HR+/HER2- High-Risk EBC?

FEATURING Bora Lim
  • 371 views
  • February 26, 2021
  • 4
06:43

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Advanced ER+ BC Highlights: Outcomes With Exemestane+/-Entinostat for Postmenopausal Women, Considering Tesetaxel+Capecitabine vs. Capecitabine Alone for HR+/HER2- mBC

FEATURING Bora Lim
  • 100 views
  • February 26, 2021
50:53

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

Fertility Preservation in Women With BC: Basic Principles & Science Behind Oncofertility, Impact on Young BC Survivors, Options for Complex Patients

FEATURING Abigail Delaney
  • 120 views
  • February 26, 2021
08:57

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS ASCENT Trial Update on mTNBC: Is Sacituzumab Govitecan More Effective Over SoC Chemo in R/R Disease?

FEATURING Ingrid Mayer
  • 111 views
  • February 23, 2021
08:07

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

Novel Therapeutics in Advanced HER2+ MBC

FEATURING Ingrid Mayer
  • 42 views
  • February 23, 2021
10:21

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

ADCs in HER2+ MBC: Durable Antitumor Activity of T-DXd in a Pretreated Patient Population

FEATURING Ingrid Mayer
  • 183 views
  • February 23, 2021
  • 1
09:24

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Update on HER2+ MBC: How Effective Is Margetuximab + Chemo After Prior Anti-HER2 Therapies? What Are the Available Management Options for 1L and Beyond?

FEATURING Ingrid Mayer
  • 99 views
  • February 23, 2021
  • 1
14:16

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Clinical Trial Data on IO in mTNBC: Do 1L Atezo or Pembro Added to Chemo Help Patients With PD-L1 Expression? Does Backbone Matter?

FEATURING Ingrid Mayer
  • 27 views
  • February 23, 2021